{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:42:05Z","timestamp":1792456925633,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,4,17]],"date-time":"2015-04-17T00:00:00Z","timestamp":1429228800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Biomed Sci"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12929-015-0134-2","type":"journal-article","created":{"date-parts":[[2015,4,16]],"date-time":"2015-04-16T18:14:17Z","timestamp":1429208057000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Antiviral activity of an N-allyl acridone against dengue virus"],"prefix":"10.1186","volume":"22","author":[{"given":"Mar\u00eda B","family":"Mazzucco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura B","family":"Talarico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sezen","family":"Vatansever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana C","family":"Carro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirta L","family":"Fascio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norma B","family":"D\u2019Accorso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cybele C","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsa B","family":"Damonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,4,17]]},"reference":[{"key":"134_CR1","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1038\/nrmicro2460","volume":"8","author":"MG Guzm\u00e1n","year":"2010","unstructured":"Guzm\u00e1n MG, Halstead SB, Artsob H, Buchy P, Farrar J, Gubler DJ, et al. Dengue: a continuing global threat. Nat Rev Microbiol. 2010;8:S7\u2013S16.","journal-title":"Nat Rev Microbiol"},{"key":"134_CR2","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1146\/annurev.micro.62.081307.163005","volume":"62","author":"JL Kyle","year":"2008","unstructured":"Kyle JL, Harris E. Global spread and persistence of dengue. Annu Rev Microbiol. 2008;62:71\u201392.","journal-title":"Annu Rev Microbiol"},{"key":"134_CR3","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nature12060","volume":"496","author":"S Bhatt","year":"2013","unstructured":"Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, et al. The global distribution and burden of dengue. Nature. 2013;496:504\u20137.","journal-title":"Nature"},{"key":"134_CR4","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1001\/jama.2013.4903","volume":"309","author":"M Mitka","year":"2013","unstructured":"Mitka M. Dengue more prevalent than previously thought. JAMA. 2013;309:1882.","journal-title":"JAMA"},{"key":"134_CR5","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.antiviral.2009.12.011","volume":"85","author":"CG Noble","year":"2010","unstructured":"Noble CG, Chen Y-L, Dong H, Gu F, Lim SP, Schul W, et al. Strategies for development of dengue virus inhibitors. Antiviral Res. 2010;85:450\u201362.","journal-title":"Antiviral Res"},{"key":"134_CR6","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.antiviral.2008.08.004","volume":"81","author":"A Sampath","year":"2009","unstructured":"Sampath A, Padmanabhan R. Molecular targets for flavivirus drug discovery. Antiviral Res. 2009;81:6\u201315.","journal-title":"Antiviral Res"},{"key":"134_CR7","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1590\/S0074-02762013000500010","volume":"108","author":"MC Borges","year":"2013","unstructured":"Borges MC, Castro LA, Da Fonseca BA. Chloroquine use improves dengue-related symptoms. Mem Inst Oswaldo Cruz. 2013;108:596\u20139.","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"134_CR8","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1093\/infdis\/jis470","volume":"207","author":"NM Nguyen","year":"2013","unstructured":"Nguyen NM, Tran CN, Phung LK, Duong KT, Huynh Hle A, Farrar J, et al. A randomized, double-blind placebo controlled trial of balapiravir, a polymerase inhibitor, in adult dengue patients. J Infect Dis. 2013;207:1442\u201350.","journal-title":"J Infect Dis"},{"key":"134_CR9","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/1745-6215-13-203","volume":"13","author":"J Whitehorn","year":"2012","unstructured":"Whitehorn J, Van Vinh CN, Truong NT, Tai LT, Van Hao N, Hien TT, et al. Lovastatin for adult patients with dengue: protocol for a randomized controlled trial. Trials. 2012;13:203.","journal-title":"Trials"},{"key":"134_CR10","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.antiviral.2013.06.011","volume":"99","author":"J Chang","year":"2013","unstructured":"Chang J, Block TM, Guo J-T. Antiviral therapies targeting host ER alpha-glucosidases: Current status and future directions. Antiviral Res. 2013;99:251\u201360.","journal-title":"Antiviral Res"},{"key":"134_CR11","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.jmb.2007.07.005","volume":"372","author":"MP Egloff","year":"2007","unstructured":"Egloff MP, Decroly E, Malet H, Selisko B, Benarroch D, Ferron F, et al. Structural and functional analysis of methylation and 5\u2019-RNA sequence requirements of short capped RNAs by the methyltransferase domain of dengue virus NS5. J Mol Biol. 2007;372:723\u201336.","journal-title":"J Mol Biol"},{"key":"134_CR12","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.antiviral.2008.06.007","volume":"80","author":"H Malet","year":"2008","unstructured":"Malet H, Mass\u00e9 N, Selisko B, Romette J-L, Alvarez K, Guillemot JC, et al. The flavivirus polymerase as a target for drug discovery. Antiviral Res. 2008;80:23\u201335.","journal-title":"Antiviral Res"},{"key":"134_CR13","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1128\/JVI.73.4.3108-3116.1999","volume":"73","author":"H Li","year":"1999","unstructured":"Li H, Clum SR, You S, Ebner KE, Padmanabhan R. The serine protease and RNA-stimulated nucleoside triphosphatase and RNA helicase functional domains of dengue virus type 2 NS3 converge within a region of 20 amino acids. J Virol. 1999;73:3108\u201316.","journal-title":"J Virol"},{"key":"134_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.antiviral.2008.05.003","volume":"80","author":"H Dong","year":"2008","unstructured":"Dong H, Zhang B, Shi P-Y. Flavivirus methyltransferase: a novel antiviral target. Antiviral Res. 2008;80:1\u201310.","journal-title":"Antiviral Res"},{"key":"134_CR15","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.antiviral.2008.07.001","volume":"80","author":"J Lescar","year":"2008","unstructured":"Lescar J, Dahai L, Xu T, Sampath A, Lim SP, Canard B, et al. Towards the design of antiviral inhibitors against flaviviruses: the case for the multifunctional NS3 protein from Dengue virus as a target. Antiviral Res. 2008;80:94\u2013101.","journal-title":"Antiviral Res"},{"key":"134_CR16","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.antiviral.2010.04.014","volume":"87","author":"B Pastorino","year":"2010","unstructured":"Pastorino B, Nougairede A, Wurtz N, Gould E, De Lamballeire X. Role of host cell factors in flavivirus infection: Implications for pathogenesis and development of antiviral drugs. Antiviral Res. 2010;87:281\u201394.","journal-title":"Antiviral Res"},{"key":"134_CR17","doi-asserted-by":"publisher","first-page":"139","DOI":"10.2174\/187152007780058669","volume":"7","author":"P Belmont","year":"2007","unstructured":"Belmont P, Bosson J, Godet T, Tiano M. Acridine and acridone derivatives, anticancer properties and synthetic methods: where are we now? Anticancer Agents Med Chem. 2007;7:139\u201369.","journal-title":"Anticancer Agents Med Chem"},{"key":"134_CR18","doi-asserted-by":"publisher","first-page":"323","DOI":"10.2174\/1568005043340533","volume":"4","author":"KF Bastow","year":"2004","unstructured":"Bastow KF. New acridone inhibitors of human herpes virus replication. Curr Drug Targets: Infect Disord. 2004;4:323\u201330.","journal-title":"Curr Drug Targets: Infect Disord"},{"key":"134_CR19","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.2174\/0929867311320190002","volume":"20","author":"CS Sep\u00falveda","year":"2013","unstructured":"Sep\u00falveda CS, Fascio ML, Garc\u00eda CC, D\u2019Accorso NB, Damonte EB. Acridones as antiviral agents: synthesis, chemical and biological properties. Curr Med Chem. 2013;20:2402\u201314.","journal-title":"Curr Med Chem"},{"key":"134_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0007376","volume":"4","author":"Z Sasvari","year":"2009","unstructured":"Sasvari Z, Bach S, Blondel M, Nagy PD. Inhibition of RNA recruitment and replication of an RNA virus by acridine derivatives with known anti-prion activities. PLoS One. 2009;4, e7376.","journal-title":"PLoS One"},{"key":"134_CR21","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1177\/095632020801900106","volume":"19","author":"CS Sep\u00falveda","year":"2008","unstructured":"Sep\u00falveda CS, Fascio ML, Mazzucco MB, Docampo Palacios ML, Pell\u00f3n RF, Garc\u00eda CC, et al. Synthesis and evaluation of N-substituted acridones as antiviral agents againts haemorrhagic fever viruses. Antivir Chem Chemother. 2008;19:41\u20137.","journal-title":"Antivir Chem Chemother"},{"key":"134_CR22","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.virol.2007.01.043","volume":"363","author":"LB Talarico","year":"2007","unstructured":"Talarico LB, Damonte EB. Interference in dengue virus adsorption and uncoating by carrageenans. Virology. 2007;363:473\u201385.","journal-title":"Virology"},{"key":"134_CR23","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.bbrc.2008.08.100","volume":"376","author":"KI Hidari","year":"2008","unstructured":"Hidari KI, Takahashi N, Arihara M, Nagaoka M, Morita K, Suzuki T. Structure and anti-dengue virus activity of sulfated polysaccharide from a marine alga. Biochem Biophys Res Commun. 2008;376:91\u20135.","journal-title":"Biochem Biophys Res Commun"},{"key":"134_CR24","doi-asserted-by":"publisher","first-page":"5269","DOI":"10.1128\/AAC.00686-10","volume":"54","author":"SJF Kaptein","year":"2010","unstructured":"Kaptein SJF, De Burghgraeve T, Froeyen M, Pastorino B, Alen MMF, Mondotte JA, et al. A derivative of the antibiotic doxorubicin is a selective inhibitor of dengue and yellow fever virus replication in vitro. Antimicrob Ag Chemother. 2010;54:5269\u201380.","journal-title":"Antimicrob Ag Chemother"},{"key":"134_CR25","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.antiviral.2005.02.001","volume":"66","author":"LB Talarico","year":"2005","unstructured":"Talarico LB, Pujol CA, Zibetti RG, Faria PC, Noseda MD, Duarte ME, et al. The antiviral activity of sulfated polysaccharides against dengue virus is dependent on virus serotype and host cell. Antiviral Res. 2005;66:103\u201310.","journal-title":"Antiviral Res"},{"key":"134_CR26","doi-asserted-by":"publisher","first-page":"3730","DOI":"10.1021\/jm070299x","volume":"50","author":"SH Watterson","year":"2007","unstructured":"Watterson SH, Chen P, Zhao Y, Gu HH, Dhar TG, Xiao Z, et al. Acridone-based inhibitors of inosine 5\u2019-monophosphate dehydrogenase: discovery and SAR leading to the identification of N-(2-(6-(4-ethylpiperazin-1-yl)pyridine-3-yl)propan-2-yl)-2-fluoro-9-oxo-9,10-dihydroxyacridine-3-carboxamide (BMS-566419). J Med Chem. 2007;50:3730\u201342.","journal-title":"J Med Chem"},{"key":"134_CR27","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1099\/vir.0.81655-0","volume":"87","author":"R Takhampunya","year":"2006","unstructured":"Takhampunya R, Ubol S, Houng H-S, Cameron CE, Padmanabhan R. Inhibition of dengue virus replication by mycophenolic acid and ribavirin. J Gen Virol. 2006;87:1947\u201352.","journal-title":"J Gen Virol"},{"key":"134_CR28","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1128\/JVI.79.3.1943-1947.2005","volume":"79","author":"P Leyssen","year":"2005","unstructured":"Leyssen P, Balzarini J, De Clercq E, Neyts J. The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase. J Virol. 2005;79:1943\u20137.","journal-title":"J Virol"},{"key":"134_CR29","first-page":"985","volume":"31","author":"GW Crabtree","year":"1971","unstructured":"Crabtree GW, Henderson JF. Rate-limiting steps in the interconversion of purine ribonucleotides in Ehrlich ascites tumor cells in vitro. Cancer Res. 1971;31:985\u201391.","journal-title":"Cancer Res"},{"key":"134_CR30","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/256331a0","volume":"256","author":"RC Jackson","year":"1975","unstructured":"Jackson RC, Weber G, Morris HP. IMP dehydrogenase, an enzyme linked with proliferation and malignancy. Nature. 1975;256:331\u20133.","journal-title":"Nature"},{"key":"134_CR31","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1021\/jm051250z","volume":"49","author":"O Tabarrini","year":"2006","unstructured":"Tabarrini O, Manfroni G, Fravolini A, Cecchetti V, Sabatini S, De Clercq E, et al. Synthesis and anti-BVDV activity of acridones as new potential antiviral agents. J Med Chem. 2006;49:2621\u20137.","journal-title":"J Med Chem."},{"key":"134_CR32","doi-asserted-by":"publisher","first-page":"3354","DOI":"10.1021\/jm801608u","volume":"52","author":"G Manfroni","year":"2009","unstructured":"Manfroni G, Paeshuyse J, Massari S, Zanoli S, Gatto B, Maga G, et al. Inhibition of subgenomic hepatitis C virus RNA replication by acridone derivatives: identification of an NS3 helicase inhibitor. J Med Chem. 2009;52:3354\u201365.","journal-title":"J Med Chem."},{"key":"134_CR33","doi-asserted-by":"publisher","first-page":"8846","DOI":"10.1016\/j.bmc.2008.08.074","volume":"16","author":"A Stankiewicz-Drogon","year":"2008","unstructured":"Stankiewicz-Drogon A, Palchykovska LG, Kostina VG, Alexeeva IV, Shved AD, Boguszewska-Chachulska AM. New acridone-4-carboxylic acid derivatives as potential inhibitors of Hepatitis C virus infection. Bioorg Med Chem. 2008;16:8846\u201352.","journal-title":"Bioorg Med Chem."},{"key":"134_CR34","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1021\/jm901741p","volume":"53","author":"A Stankiewicz-Drogon","year":"2010","unstructured":"Stankiewicz-Drogon A, Dorner B, Erker T, Boguszewska-Chachulska AM. Synthesis of new acridone derivatives, inhibitors of NS3 helicase, which efficiently and specifically inhibit subgenomic HCV replication. J Med Chem. 2010;53:3117\u201326.","journal-title":"J Med Chem."},{"key":"134_CR35","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1177\/095632020701800501","volume":"18","author":"V Nair","year":"2007","unstructured":"Nair V, Shu Q. Inosine monophosphate dehydrogenase as a probe in antiviral drug discovery. Antiviral Chem Chemother. 2007;18:245\u201358.","journal-title":"Antiviral Chem Chemother"},{"key":"134_CR36","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1006\/viro.2002.1685","volume":"304","author":"MS Diamond","year":"2002","unstructured":"Diamond MS, Zachariah M, Harris E. Mycophenolic acid inhibits dengue virus infection by preventing replication of viral RNA. Virology. 2002;304:211\u201321.","journal-title":"Virology"},{"key":"134_CR37","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1128\/AAC.44.4.859-866.2000","volume":"44","author":"W Markland","year":"2000","unstructured":"Markland W, McQuaid TJ, Jain J, Kwong AD. Broad-spectrum antiviral activity of the IMP dehydrogenase inhibitor VX-497: a comparison with ribavirin and demonstration of antiviral additivity with alpha interferon. Antimicrob Agents Chemother. 2000;44:859\u201366.","journal-title":"Antimicrob Agents Chemother"},{"key":"134_CR38","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1016\/j.bmcl.2009.01.031","volume":"19","author":"V Nair","year":"2009","unstructured":"Nair V, Chi G, Shu Q, Julander J, Smee DF. A heterocyclic molecule with significant activity against dengue virus. Bioorg Med Chem Lett. 2009;19:1425\u20137.","journal-title":"Bioorg Med Chem Lett"},{"key":"134_CR39","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.antiviral.2010.04.007","volume":"87","author":"M McDowell","year":"2010","unstructured":"McDowell M, Gonzales SR, Kumarapperuma SC, Jeselnik M, Arterburn JB, Hanley KA. A novel nucleoside analog, 1-\u03b2-D-ribofuranosyl-3-ehynyl-[1,2,4]triazole (ETAR) exhibits efficacy against a broad range of flaviviruses in vitro. Antiviral Res. 2010;87:78\u201380.","journal-title":"Antiviral Res"},{"key":"134_CR40","doi-asserted-by":"crossref","first-page":"3683","DOI":"10.1128\/AAC.00561-10","volume":"54","author":"M Qing","year":"2010","unstructured":"Qing M, Zou G, Wang Q-Y, Xu HY, Dong H, Yuan Z, et al. Characterization of dengue virus resistance to brequinar in cell culture. Antimicrob Agents Chemother. 2010;54:3683\u201395.","journal-title":"Antimicrob Agents Chemother"},{"key":"134_CR41","doi-asserted-by":"publisher","first-page":"6548","DOI":"10.1128\/JVI.02510-10","volume":"85","author":"Q-Y Wang","year":"2011","unstructured":"Wang Q-Y, Bushell S, Qing M, Xu HY, Bonavia A, Nunes S, et al. Inhibition of dengue virus through suppression of host pyrimidine biosynthesis. J Virol. 2011;85:6548\u201356.","journal-title":"J Virol"},{"key":"134_CR42","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3851\/IMP1763","volume":"16","author":"MC Dunn","year":"2011","unstructured":"Dunn MC, Knight DA, Waldman WJ. Inhibition of respiratory syncytial virus in vitro and in vivo by the immunosuppresive agent leflunomide. Antivir Ther. 2011;16:309\u201317.","journal-title":"Antivir Ther"},{"key":"134_CR43","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.antiviral.2013.10.003","volume":"100","author":"M Marschall","year":"2013","unstructured":"Marschall M, Niemann I, Kosulin K, Bootz A, Wagner S, Dobner T, et al. Assessment of drug candidates for broad-spectrum antiviral therapy targeting cellular pyrimidine biosynthesis. Antiviral Res. 2013;100:640\u20138.","journal-title":"Antiviral Res"},{"key":"134_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003084","volume":"8","author":"S Kang","year":"2014","unstructured":"Kang S, Shields AR, Jupatanakul N, Dimopoulos G. Suppressing dengue-2 infection by chemical inhibition of Aedes aegypti host factors. PLoS Negl Trop Dis. 2014;8, e3084.","journal-title":"PLoS Negl Trop Dis"},{"key":"134_CR45","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.antiviral.2011.10.007","volume":"93","author":"CS Sep\u00falveda","year":"2012","unstructured":"Sep\u00falveda CS, Garc\u00eda CC, Fascio ML, D\u2019Accorso NB, Docampo Palacios ML, Pell\u00f3n RF, et al. Inhibition of Jun\u00edn virus RNA synthesis by an antiviral acridone derivative. Antiviral Res. 2012;93:16\u201322.","journal-title":"Antiviral Res"}],"container-title":["Journal of Biomedical Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12929-015-0134-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-015-0134-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-015-0134-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-015-0134-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T11:02:29Z","timestamp":1630580549000},"score":1,"resource":{"primary":{"URL":"https:\/\/jbiomedsci.biomedcentral.com\/articles\/10.1186\/s12929-015-0134-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,17]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["134"],"URL":"https:\/\/doi.org\/10.1186\/s12929-015-0134-2","relation":{},"ISSN":["1423-0127"],"issn-type":[{"value":"1423-0127","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,17]]},"assertion":[{"value":"20 August 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"29"}}